Last update 08 May 2025

Cytavis Biopharma GmbH

Dissolved
| Private Company|Germany

Overview

Related

1
Drugs associated with Cytavis Biopharma GmbH
Aviscumine
Target-
Mechanism
28S rRNA inhibitors
Active Org.-
Originator Org.
Cytavis Biopharma GmbH
Active Indication-
Inactive Indication
Malignant melanoma stage IV [+3]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Cytavis Biopharma GmbH
NCT00932724
/ TerminatedPhase 2
Phase II Double-blind Placebo-controlled Trial of CY503 in Patients With Chemotherapy-refractory Metastatic Colorectal Cancer
NCT00658437
/ CompletedPhase 2
A Phase II Multicenter Study to Test Progression-free and Overall Survival of CY-503 in the Treatment of Patients With Unresectable Stage IV Metastatic Melanoma After Antineoplastic Treatment Failure
100 Clinical Results associated with Cytavis Biopharma GmbH
Login to view more data
0 Patents (Medical) associated with Cytavis Biopharma GmbH
Login to view more data
100 Deals associated with Cytavis Biopharma GmbH
Login to view more data
100 Translational Medicine associated with Cytavis Biopharma GmbH
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 Dec 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Aviscumine
Metastatic colon cancer
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free